Doris Spatz takes a once-a-day pill, Kisqali, to keep her metastatic breast cancer in check. As a patient in the Defense Department health system, she can fill routine prescriptions at a military pharmacy without a copay ...
Nov 9, 2022
0
3
The latest government study on teen vaping suggests there's been little progress in keeping e-cigarettes out of the hands of kids.
Oct 6, 2022
0
4
In the fall of 2018, cancer researcher Corrie Painter began presenting some intriguing early results from a new study on a rare and deadly cancer known as angiosarcoma. She and her fellow scientists hoped that by sharing ...
Sep 14, 2022
0
8
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.
Sep 7, 2022
0
4
Federal health regulators remain unconvinced about the benefits of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, even as they prepare to give its drugmaker a rare second opportunity ...
Sep 2, 2022
0
2
Family physician Jennifer Vassel used to think she was weird. Situations affected her differently than her colleagues. She could remember exact pages from her Grade 6 textbooks. And she had always been highly sensitive to ...
Jul 6, 2022
2
4
Close to half of the roughly two dozen states where abortion is or will soon be outlawed or heavily restricted do not require sex education.
Jul 5, 2022
0
10
U.S. regulators will soon begin cracking down on vaping companies using a now-closed loophole, including a line of fruit-flavored e-cigarettes that have become teenagers' top choice.
Apr 14, 2022
0
2
Wylie James Prescott, 3, had to wait more than a year after his autism diagnosis to begin behavioral therapy, even though research shows early treatment of autism can be crucial for children's long-term development.
Apr 4, 2022
0
39
Advocacy groups are pressing U.S. federal regulators to fast-track approval of an experimental drug treatment for the deadly neurological disease ALS (amyotrophic lateral sclerosis), with a decision expected this week.
Mar 28, 2022
0
13
